These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 2488467)

  • 1. Captopril in temporary, non-dialytic management of pulmonary edema in end-stage renal disease.
    Hruby ZW; Kuźniar J; Szewczyk Z
    Mater Med Pol; 1989; 21(2):134-6. PubMed ID: 2488467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HHV-8 positive Kaposi sarcoma in a patient with end-stage renal disease undergoing hemodialysis: no regressive effect of captopril.
    Yaşar S; Mansur AT; Göktay F; Aydingöz IE
    Eur J Dermatol; 2007; 17(2):153-6. PubMed ID: 17337401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Tensiomin in hypertensive patients with impaired renal function.
    Makó J; Potyondi M
    Ther Hung; 1992; 40(1):20-4. PubMed ID: 1585279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe side-effects of captopril in advanced chronic kidney insufficiency.
    Beroniade V
    Proc Eur Dial Transplant Assoc; 1983; 20():530-7. PubMed ID: 6228942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term survival of incident hemodialysis patients who are hospitalized for congestive heart failure, pulmonary edema, or fluid overload.
    Banerjee D; Ma JZ; Collins AJ; Herzog CA
    Clin J Am Soc Nephrol; 2007 Nov; 2(6):1186-90. PubMed ID: 17942779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flash pulmonary edema in patients with chronic kidney disease and end stage renal disease.
    Headley CM; Wall BM
    Nephrol Nurs J; 2007; 34(1):15-26, 37; quiz 27-8. PubMed ID: 17345689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term treatment with captopril in arterial hypertension complicated by renal failure].
    Durand D; Ader JL; Emal V; Bories P; Girolami JP; Suc JM
    Arch Mal Coeur Vaiss; 1982 Jun; 75 Spec No():151-6. PubMed ID: 6126168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of captopril-bound Fe by end-stage renal failure patients during hemodialysis.
    Averbukh Z; Berman S; Kishinevsky E; Feldman L; Cohn M; Rapoport M; Galperin E; Dishi V; Weissgarten J
    J Nephrol; 2004; 17(1):101-6. PubMed ID: 15151265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Combined captopril and labetalol treatment of malignant arterial hypertension (author's transl)].
    El Matri A; Kechrid C; Larabi M; Belkahia C; Ben Ayed H
    Nouv Presse Med; 1981 Apr; 10(19):1575-8. PubMed ID: 7025848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperglycemia causing pulmonary edema in patients with end-stage renal disease.
    Singhal PC; Desroches L; Ayer S; Abramovici M; Venkatesan J
    Clin Nephrol; 1991 Oct; 36(4):210-1. PubMed ID: 1959247
    [No Abstract]   [Full Text] [Related]  

  • 12. Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis.
    Wong CF; McCarthy M; Howse ML; Williams PS
    Ren Fail; 2007; 29(6):653-9. PubMed ID: 17763158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Successful treatment of renal hypertension in a 2 1/2-year-old girl with the converting enzyme inhibitor captopril (author's transl)].
    Lütkenhaus C; Bonzel K; Diekmann L; Koch H
    Monatsschr Kinderheilkd; 1980 Nov; 128(11):724-6. PubMed ID: 6110181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.
    Bossola M; Tazza L; Merki E; Giungi S; Luciani G; Miller ER; Lin EB; Tortorelli A; Tsimikas S
    Blood Purif; 2007; 25(5-6):457-65. PubMed ID: 18075247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
    Nasri H; Baradaran A
    J Ayub Med Coll Abbottabad; 2004; 16(2):3-8. PubMed ID: 15455608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of light exercise on renal hemodynamics in patients with hypertension and chronic renal disease.
    Svarstad E; Myking O; Ofstad J; Iversen BM
    Scand J Urol Nephrol; 2002; 36(6):464-72. PubMed ID: 12623513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Captopril (Tensiomin) in the treatment of chronic heart failure of ischaemic heart disease patients.
    Palócz E; Kerkovits G
    Ther Hung; 1989; 37(4):220-4. PubMed ID: 2698519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Captopril in hypertension after renal transplantation.
    Herlitz H; Ahlmén J; Aurell M; Blohmé I; Brynger H; Delin K; Larsson O
    Scand J Urol Nephrol Suppl; 1984; 79():111-4. PubMed ID: 6382584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
    Lebel M; Rodrigue ME; Agharazii M; Larivière R
    Am J Hypertens; 2006 Dec; 19(12):1286-92. PubMed ID: 17161776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Theophylline toxicity risks and chronic renal failure.
    Nicot G; Charmes JP; Lachatre G; Sautereau D; Valette JP; Eichler B; Leroux-Robert C
    Int J Clin Pharmacol Ther Toxicol; 1989 Aug; 27(8):398-401. PubMed ID: 2793275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.